Invited review: Maximizing value and minimizing waste in clinical trial research in dairy cattle: Selecting interventions and outcomes to build an evidence base

被引:3
作者
Sargeant, Jan M. [1 ]
O'Connor, Annette M. [2 ]
LeBlanc, Stephen J. [1 ]
Winder, Charlotte B. [1 ]
机构
[1] Univ Guelph, Dept Populat Med, Guelph, ON N1G2W1, Canada
[2] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA
关键词
experiment; clinical trial; interventions; outcomes; RANDOMIZED CONTROLLED-TRIALS; REPORTING GUIDELINES; COMPARATIVE EFFICACY; SYSTEMATIC REVIEWS; MASTITIS; COWS; PREVENTION; METRITIS; ANTIMICROBIALS; EXPLANATION;
D O I
10.3168/jds.2022-22015
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Clinical trials are a valuable study design for evalu-ating interventions when it is ethical and feasible for investigators to randomly allocate study animals to intervention groups. Researchers may choose to evalu-ate the comparative efficacy of intervention groups for their effect on outcomes that are relevant to the specific objectives of their trial. However, the results across multiple trials on the same intervention and with the same outcome should be considered when making decisions on whether to use an intervention, because the results of a single trial are subject to sampling error and do not reflect all biological variability. The objective of this review was to provide an overview of important concepts when selecting intervention groups and outcomes within a randomized controlled trial, and when building a body of evidence for intervention efficacy across multiple trials. Empirical evidence is presented to highlight that integrating and interpreting the efficacy of an intervention across trials is hindered by a lack of replication of interventions across trials. Inconsistency in the outcomes and their measurement among trials also limits the ability to build a body of evidence for the efficacy of interventions. The devel-opment of core outcome sets for specific topic areas in dairy science, updated as necessary, may improve consistency across trials and aid in the development of a body of evidence for evidence-based decision-making.
引用
收藏
页码:8594 / 8608
页数:15
相关论文
共 57 条
[1]   Understanding measures of treatment effect in clinical trials [J].
Akobeng, AK .
ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 (01) :54-56
[2]   The Levels of Evidence and Their Role in Evidence-Based Medicine [J].
Burns, Patricia B. ;
Rohrich, Rod J. ;
Chung, Kevin C. .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 128 (01) :305-310
[3]   Avoidable waste in the production and reporting of research evidence [J].
Chalmers, Iain ;
Glasziou, Paul .
LANCET, 2009, 374 (9683) :86-89
[4]   Methodology of superiority vs. equivalence trials and non-inferiority trials [J].
Christensen, Erik .
JOURNAL OF HEPATOLOGY, 2007, 46 (05) :947-954
[5]  
de Lima FS, 2020, ANIM REPROD, V17, DOI [10.1590/1984-3143-AR2020-0063, 10.1590/1984-3143-ar2020-0063]
[6]   Deficiencies of effectiveness of intervention studies in veterinary medicine: a cross-sectional survey of ten leading veterinary and medical journals [J].
Di Girolamo, Nicola ;
Reynders, Reint Meursinge .
PEERJ, 2016, 4
[7]   What outcomes should be measured in feline chronic kidney disease treatment trials? Establishing a core outcome set for research [J].
Doit, H. ;
Dean, R. S. ;
Duz, M. ;
Finch, N. C. ;
Brennan, M. L. .
PREVENTIVE VETERINARY MEDICINE, 2021, 192
[8]   Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias - An Updated Review [J].
Dwan, Kerry ;
Gamble, Carrol ;
Williamson, Paula R. ;
Kirkham, Jamie J. .
PLOS ONE, 2013, 8 (07)
[9]  
FDA (Food and Drug Administration), 2021, BIOM SURR ENDP CLIN
[10]  
Fffff K.F., 2010, FFFBMC MED, V8, DOI [10.1186/1741-7015-8-18ffff, DOI 10.1186/1741-7015-8-18FFFF]